219 related articles for article (PubMed ID: 23338796)
1. Safety and efficacy of thrombolysis with intravenous alteplase in older stroke patients.
Sarikaya H
Drugs Aging; 2013 Apr; 30(4):227-34. PubMed ID: 23338796
[TBL] [Abstract][Full Text] [Related]
2. TESPI (Thrombolysis in Elderly Stroke Patients in Italy): a randomized controlled trial of alteplase (rt-PA) versus standard treatment in acute ischaemic stroke in patients aged more than 80 years where thrombolysis is initiated within three hours after stroke onset.
Lorenzano S; Toni D;
Int J Stroke; 2012 Apr; 7(3):250-7. PubMed ID: 22292526
[TBL] [Abstract][Full Text] [Related]
3. Comparative Analysis on Low- and Standard-Dose Regimes of Alteplase Thrombolytic Therapy for Acute Ischemic Stroke: Efficacy and Safety.
Zhao G; Huang T; Zheng M; Cui Y; Liu Y; Cheng Z; Wang Z
Eur Neurol; 2018; 79(1-2):68-73. PubMed ID: 29241193
[TBL] [Abstract][Full Text] [Related]
4. Thrombolysis with alteplase 3-4.5 hours after acute ischaemic stroke: the first multicentre, phase III trial in China.
Zheng H; Yang Y; Chen H; Li C; Chen Y; Shi FD; Yang L; Cui X; Lu Z; Liang Y; Cui S; Xu A; Wu Y; Sun Y; Wang Y
Stroke Vasc Neurol; 2020 Sep; 5(3):285-290. PubMed ID: 32467323
[TBL] [Abstract][Full Text] [Related]
5. Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age.
Kono S; Deguchi K; Morimoto N; Kurata T; Yamashita T; Ikeda Y; Narai H; Manabe Y; Takao Y; Kawada S; Kashihara K; Takehisa Y; Inoue S; Kiriyama H; Abe K
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1175-83. PubMed ID: 23507462
[TBL] [Abstract][Full Text] [Related]
6. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial.
Anderson CS; Huang Y; Lindley RI; Chen X; Arima H; Chen G; Li Q; Billot L; Delcourt C; Bath PM; Broderick JP; Demchuk AM; Donnan GA; Durham AC; Lavados PM; Lee TH; Levi C; Martins SO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Silva F; Song L; Thang NH; Wardlaw JM; Wang JG; Wang X; Woodward M; Chalmers J; Robinson TG;
Lancet; 2019 Mar; 393(10174):877-888. PubMed ID: 30739745
[TBL] [Abstract][Full Text] [Related]
7. MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset.
Thomalla G; Simonsen CZ; Boutitie F; Andersen G; Berthezene Y; Cheng B; Cheripelli B; Cho TH; Fazekas F; Fiehler J; Ford I; Galinovic I; Gellissen S; Golsari A; Gregori J; Günther M; Guibernau J; Häusler KG; Hennerici M; Kemmling A; Marstrand J; Modrau B; Neeb L; Perez de la Ossa N; Puig J; Ringleb P; Roy P; Scheel E; Schonewille W; Serena J; Sunaert S; Villringer K; Wouters A; Thijs V; Ebinger M; Endres M; Fiebach JB; Lemmens R; Muir KW; Nighoghossian N; Pedraza S; Gerloff C;
N Engl J Med; 2018 Aug; 379(7):611-622. PubMed ID: 29766770
[TBL] [Abstract][Full Text] [Related]
8. SYNTHESIS expansion: design of a nonprofit, pragmatic, randomized, controlled trial on the best fast-track endovascular treatment vs. standard intravenous alteplase for acute ischemic stroke.
Ciccone A; Valvassori L; Nichelatti M;
Int J Stroke; 2011 Jun; 6(3):259-65. PubMed ID: 21557814
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Tirofiban Administered at Different Time Points after Intravenous Thrombolytic Therapy with Alteplase in Patients with Acute Ischemic Stroke.
Liu J; Shi Q; Sun Y; He J; Yang B; Zhang C; Guo R
J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):1126-1132. PubMed ID: 30655038
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of Endovascular Thrombectomy with and without Thrombolysis for Acute Large Artery Ischaemic Stroke at a Tertiary Stroke Centre.
Wee CK; McAuliffe W; Phatouros CC; Phillips TJ; Blacker D; Singh TP; Baker E; Hankey GJ
Cerebrovasc Dis Extra; 2017; 7(2):95-102. PubMed ID: 28463832
[TBL] [Abstract][Full Text] [Related]
11. Intravenous alteplase at 0.6 mg/kg for acute stroke patients with basilar artery occlusion: the stroke acute management with urgent risk factor assessment and improvement (SAMURAI) Recombinant tissue plasminogen activator registry.
Miyagi T; Koga M; Shiokawa Y; Nakagawara J; Hasegawa Y; Furui E; Kimura K; Kario K; Okuda S; Yamagami H; Okada Y; Nezu T; Maeda K; Endo K; Minematsu K; Toyoda K
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1098-106. PubMed ID: 23063059
[TBL] [Abstract][Full Text] [Related]
12. Thrombolysis for acute ischaemic stroke.
Wardlaw JM; Zoppo G; Yamaguchi T; Berge E
Cochrane Database Syst Rev; 2003; (3):CD000213. PubMed ID: 12917889
[TBL] [Abstract][Full Text] [Related]
13. Extending the time window for intravenous thrombolysis in acute ischemic stroke using magnetic resonance imaging-based patient selection.
Ringleb P; Bendszus M; Bluhmki E; Donnan G; Eschenfelder C; Fatar M; Kessler C; Molina C; Leys D; Muddegowda G; Poli S; Schellinger P; Schwab S; Serena J; Toni D; Wahlgren N; Hacke W;
Int J Stroke; 2019 Jul; 14(5):483-490. PubMed ID: 30947642
[TBL] [Abstract][Full Text] [Related]
14. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
[TBL] [Abstract][Full Text] [Related]
15. The efficacy and safety of intravenous thrombolysis with alteplase in the treatment of ischaemic stroke in a rural hospital.
Sobolewski P; Sledzińska-Dźwigał M; Szczuchniak W; Hatalska-Żerebiec R; Grzesik M; Sobota A
Neurol Neurochir Pol; 2013; 47(4):310-8. PubMed ID: 23986420
[TBL] [Abstract][Full Text] [Related]
16. Quality of Life After Off-Label Thrombolysis for Ischemic Stroke in Elderly Patients.
Diard-Detoeuf C; Debiais S; Imbert M; Musikas A; Gaudron M; Laurent E; De Toffol B; Hommet C; Mondon K
Drugs Aging; 2015 Nov; 32(11):917-26. PubMed ID: 26446151
[TBL] [Abstract][Full Text] [Related]
17. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
[TBL] [Abstract][Full Text] [Related]
18. Thrombolysis with alteplase 4.5-6 hours after acute ischemic stroke.
Zhang B; Sun XJ; Ju CH
Eur Neurol; 2011; 65(3):170-4. PubMed ID: 21372577
[TBL] [Abstract][Full Text] [Related]
19. Intravenous Thrombolysis in Unknown-Onset Stroke: Results From the Safe Implementation of Treatment in Stroke-International Stroke Thrombolysis Registry.
Dorado L; Ahmed N; Thomalla G; Lozano M; Malojcic B; Wani M; Millán M; Tomek A; Dávalos A
Stroke; 2017 Mar; 48(3):720-725. PubMed ID: 28174326
[TBL] [Abstract][Full Text] [Related]
20. Utilization and outcomes with low dose tissue plasminogen activator as intravenous thrombolytic therapy for ischaemic stroke at Aga Khan University Hospital, Karachi: a retrospective analysis.
Zaman Babar MU; Khan AZ; Hakim H; Gilani J; Wasay M
J Pak Med Assoc; 2019 Nov; 69(11):1705-1710. PubMed ID: 31740883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]